References
1. Tyunyaeva N.O., Sofronova L.V. Infectious mononucleosis: etiological factors, diagnosis and treatment problems. Vestnik novykh meditsinskikh tekhnologiy [Bulletin of New Medical Technologies]. 2014; 1 (3): 184–90. (in Russian)
2. Womack J., Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015; 91 (6): 372–6.
3. Naughton P., Healy M., Enright F., et al. Infectious mononucleosis: diagnosis and clinical interpretation. Br J Biomed Sci. 2021; 78 (3): 107–16. DOI: https://doi.org/10.1080/09674845.2021.1903683
4. Belova E.G., Vengerov Yu.Ya. Infectious mononucleosis. In: N.D. Yushchuk, Yu.Ya. Vengerov (eds). Infectious Diseases. National guideline. 3rd ed., revised and additional. Moscow: GEOTAR-Media, 2021: 833–40. (in Russian)
5. Solomay T.V., Semenenko T.A., Filatov N.N., Vedunova S.L., Lavrov V.F., Smirnova D.I., et al. Reactivation of Epstein-Barr virus (Herpesviridae: Lymphocryptovirus, HHV-4) infection during COVID-19: epidemiological features. Voprosy virusologii [Problems of Virology]. 2021; 66 (2): 152–61. DOI: https://doi.org/10.36233/0507-4088-40 (in Russian)
6. García-Martínez F.J., Moreno-Artero E., Jahnke S. SARS-CoV-2 and EBV coinfection. Med Clin (Engl Ed). 2020; 155 (7): 319–20. DOI: https://doi.org/10.1016/j.medcle.2020.06.010
7. Kawaura R., Utakata R., Kondo D., et al. A case found to be severe acute respiratory syndrome coronavirus 2 positive immediately before hospitalization for infectious mononucleosis. Cureus. 2021; 13 (11): e19344. DOI: https://doi.org/10.7759/cureus.19344 PMID: 34909305; PMCID: PMC8653932.
8. Fukuda M., Amano Y., Masumura C., et al. Development of infectious mononucleosis as an unusual manifestation of COVID-19. Auris Nasus Larynx. 2021: pii: S0385-8146(21)00129-2. DOI: https://doi.org/10.1016/j.anl.2021.04.005
9. El-Anwar M.W., Eesa M., Mansour W., et al. Analysis of ear, nose and throat manifestations in COVID-19 patients. Int Arch Otorhinolaryngol. 2021; 25 (3): e343–48. DOI: https://doi.org/10.1055/s-0041-1730456
10. Guan W.J., Ni Z.Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708–20.
11. De Paschale M., Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012; 1 (1): 31–43. DOI: https://doi.org/10.5501/wjv.v1.i1.31
12. Lyashenko Yu.I., Pavlovich D.A., Finogeev Yu.P., et al. Differential diagnosis diphtheria adults. Zhurnal infektologii [Journal of Infectology]. 2010; 2 (4): 6–14. DOI: https://doi.org/10.22625/2072-6732-2010-2-4-6-1411 (in Russian)
13. Nin C. S., de Souza V.V.S., do Amaral R.H., et al. Thoracic lymphadenopathy in benign diseases: a state of the art review. Respir Med. 2016; 112: 10–7. DOI: https://doi.org/10.1016/j.rmed.2016.01.021
14. Mughal M.S., Rehman R., Osman R., et al. Hilar lymphadenopathy, a novel finding in the setting of coronavirus disease (COVID-19): a case report. J Med Case Rep. 2020; 14 (1): 1–5. DOI: https://doi.org/10.1186/s13256-020-02452-3
15. Kanakry J.A., Hegde A.M., Durand C.M., et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016; 127 (16): 2007–17. DOI: https://doi.org/10.1182/blood-2015-09-672030